Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2020

01-12-2020 | Pulmonary Emphysema | Research article

Risk factors associated with the detection of pulmonary emphysema in older asymptomatic respiratory subjects

Authors: Ivette Buendia-Roldan, Alexia Palma-Lopez, Danaireth Chan-Padilla, Iliana Herrera, Mariel Maldonado, Rosario Fernández, David Martínez-Briseño, Mayra Mejia, Moises Selman

Published in: BMC Pulmonary Medicine | Issue 1/2020

Login to get access

Abstract

Background

Several lung structural and functional abnormalities may occur associated with aging, including emphysema. In this study, we evaluated the frequency and risk factors associated with emphysema in respiratory asymptomatic individuals enrolled in our Lung Aging Program. From a cohort of 687 subjects, we found by high-resolution computed tomography (HRCT) 29 individuals (4%) with emphysematous changes that were compared with 87 controls (3:1) randomly selected from the same cohort.

Methods

This was a transversal, observational, case-control study where we examined demographics and functional characteristics, as well as telomere length and serum Klotho concentration, two conditions that have been associated with aging and some aging-associated diseases including emphysema.

Results

Individuals with subclinical pulmonary emphysema were older (72 ± 9 versus 67 ± 6 years), and primarily smoker males with low body mass index. Despite that they were asymptomatic, two of them exhibited a decrease of forced expiratory volume in 1 s (FEV1), with a lower FEV1/FVC suggesting airway obstruction. Cigarette smoking (OR = 5.43, CI95% 1.8–16.7), family history of lung disease (OR = 4.32, CI95% 1.0–19.0) and lower body mass index (OR 7.22, CI95% 1.2–3.5) were risk factors for the development of lung emphysematous changes. No association was found with telomere length and Klotho serum concentration.

Conclusion

Our findings reveal that a small but important percentage of older people without respiratory symptoms, present pulmonary emphysema and indicate that smoking exposure and genetic background may contribute to etiological factors.
Literature
1.
go back to reference Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999;13:197–205.CrossRef Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999;13:197–205.CrossRef
2.
go back to reference Silva M, Milanese G, Sverzellati N. Interstitial lung abnormalities: prognostic stratification of subtle radiological findings. Curr Opin Pulm Med. 2018;24:432–9.CrossRef Silva M, Milanese G, Sverzellati N. Interstitial lung abnormalities: prognostic stratification of subtle radiological findings. Curr Opin Pulm Med. 2018;24:432–9.CrossRef
3.
go back to reference Fukuchi Y. The aging lung and chronic obstructive pulmonary disease: similarity and difference. Proc Am Thorac Soc. 2009;6:570–2.CrossRef Fukuchi Y. The aging lung and chronic obstructive pulmonary disease: similarity and difference. Proc Am Thorac Soc. 2009;6:570–2.CrossRef
4.
go back to reference Selman M, Martinez FJ, Pardo A. Why an aging smoker lung develops IPF and not COPD? Am J Respir Crit Care Med. 2019;199:279–85.CrossRef Selman M, Martinez FJ, Pardo A. Why an aging smoker lung develops IPF and not COPD? Am J Respir Crit Care Med. 2019;199:279–85.CrossRef
5.
go back to reference Hazari YM, Bashir A, Habib M, Bashir S, Habib H, Qasim MA, et al. Alpha-1-antitrypsin deficiency: genetic variations, clinical manifestations and therapeutic interventions. Mutat Res. 2017;773:14–25.CrossRef Hazari YM, Bashir A, Habib M, Bashir S, Habib H, Qasim MA, et al. Alpha-1-antitrypsin deficiency: genetic variations, clinical manifestations and therapeutic interventions. Mutat Res. 2017;773:14–25.CrossRef
6.
go back to reference Birch J, Anderson RK, Correia-Melo C, Jurk D, Hewitt G, Marques FM, et al. DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2015;309:L1124–37.CrossRef Birch J, Anderson RK, Correia-Melo C, Jurk D, Hewitt G, Marques FM, et al. DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2015;309:L1124–37.CrossRef
7.
go back to reference Kureya Y, Kanazawa H, Ijiri N, Tochino Y, Watanabe T, Asai K, et al. Down-regulation of soluble α-klotho is associated with reduction in serum irisin levels in chronic obstructive pulmonary disease. Lung. 2016;194:345–51.CrossRef Kureya Y, Kanazawa H, Ijiri N, Tochino Y, Watanabe T, Asai K, et al. Down-regulation of soluble α-klotho is associated with reduction in serum irisin levels in chronic obstructive pulmonary disease. Lung. 2016;194:345–51.CrossRef
8.
go back to reference Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875–81.CrossRef Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875–81.CrossRef
9.
go back to reference Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e47.CrossRef Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e47.CrossRef
10.
go back to reference Kureya Y, Kanazawa H, Ijiri N, Tochino Y, Watanabe T, Asai K, et al. Down-regulation of soluble α-klotho is associated with reduction in serum Irisin levels in chronic obstructive pulmonary disease. Lung. 2016;194:345–51.CrossRef Kureya Y, Kanazawa H, Ijiri N, Tochino Y, Watanabe T, Asai K, et al. Down-regulation of soluble α-klotho is associated with reduction in serum Irisin levels in chronic obstructive pulmonary disease. Lung. 2016;194:345–51.CrossRef
11.
go back to reference Thurlbeck WM, Müller NL. Emphysema: definition, imaging, and quantification. AJR Am J Roentgenol. 1994;163:1017–25.CrossRef Thurlbeck WM, Müller NL. Emphysema: definition, imaging, and quantification. AJR Am J Roentgenol. 1994;163:1017–25.CrossRef
12.
go back to reference Torres-Durán M, Lopez-Campos JL, Barrecheguren M, Miravitlles M, Martinez-Delgado B, Castillo S, et al. Alpha-1 antitrypsin deficiency: outstanding questions and future directions. Orphanet J Rare Dis. 2018;13:114.CrossRef Torres-Durán M, Lopez-Campos JL, Barrecheguren M, Miravitlles M, Martinez-Delgado B, Castillo S, et al. Alpha-1 antitrypsin deficiency: outstanding questions and future directions. Orphanet J Rare Dis. 2018;13:114.CrossRef
13.
go back to reference Stanley SE, Merck SJ, Armanios M. Telomerase and the genetics of emphysema susceptibility. Implications for pathogenesis paradigms and patient care. Ann Am Thorac Soc. 2016;Suppl 5:S447–51.CrossRef Stanley SE, Merck SJ, Armanios M. Telomerase and the genetics of emphysema susceptibility. Implications for pathogenesis paradigms and patient care. Ann Am Thorac Soc. 2016;Suppl 5:S447–51.CrossRef
14.
go back to reference Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.CrossRef Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.CrossRef
15.
go back to reference Alcaide AB, Sanchez-Salcedo P, Bastarrika G. Clinical features of smokers with radiological emphysema but without airway limitation. Chest. 2017;151:358–65.CrossRef Alcaide AB, Sanchez-Salcedo P, Bastarrika G. Clinical features of smokers with radiological emphysema but without airway limitation. Chest. 2017;151:358–65.CrossRef
16.
go back to reference De Torres JP, Bastarrika G, Winsivesky JP, Alcaide AB, Campo A, Seijo LM, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007;132:1932–8.CrossRef De Torres JP, Bastarrika G, Winsivesky JP, Alcaide AB, Campo A, Seijo LM, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007;132:1932–8.CrossRef
17.
go back to reference Yang Y, Mao J, Ye Z, Li J, Zhao H, Liu Y. Risk factors of chronic obstructive pulmonary disease among adults in Chinese mainland: a systematic review and meta-analysis. Respir Med. 2017;131:158–65.CrossRef Yang Y, Mao J, Ye Z, Li J, Zhao H, Liu Y. Risk factors of chronic obstructive pulmonary disease among adults in Chinese mainland: a systematic review and meta-analysis. Respir Med. 2017;131:158–65.CrossRef
18.
go back to reference Hersh CP, Hokanson JE, Lynch DA, Washko GR, Make BJ, Crapo JD. Silverman EK; COPDGene Investigators. Family history is a risk factor for COPD. Chest. 2011;140:343–50.CrossRef Hersh CP, Hokanson JE, Lynch DA, Washko GR, Make BJ, Crapo JD. Silverman EK; COPDGene Investigators. Family history is a risk factor for COPD. Chest. 2011;140:343–50.CrossRef
19.
go back to reference Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLoS Med. 2018;15:e1002718.CrossRef Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLoS Med. 2018;15:e1002718.CrossRef
20.
go back to reference Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. Correction: a new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLoS Med. 2019;16:e1002760.CrossRef Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. Correction: a new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLoS Med. 2019;16:e1002760.CrossRef
Metadata
Title
Risk factors associated with the detection of pulmonary emphysema in older asymptomatic respiratory subjects
Authors
Ivette Buendia-Roldan
Alexia Palma-Lopez
Danaireth Chan-Padilla
Iliana Herrera
Mariel Maldonado
Rosario Fernández
David Martínez-Briseño
Mayra Mejia
Moises Selman
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2020
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-01204-9

Other articles of this Issue 1/2020

BMC Pulmonary Medicine 1/2020 Go to the issue